83 International Experts Submit Letter to FDA Encouraging Approval of Ataluren

PPMD applauds the group of 83 international experts with experience caring for Duchenne patients around the globe who have written a letter to the FDA encouraging approval of ataluren. With hundreds of patients accessing ataluren through the conditional approval by EMA, these physicians have first-hand experience observing the impact of the drug in a real-world setting. We will continue to work on behalf of the Duchenne community towards U.S. access and approval of ataluren for every single one.

Click here to view the letter.

Views: 851


You need to be a member of PPMD Community to add comments!

Join PPMD Community

Need help using this community site? Visit Ning's Help Page.



© 2021   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service